Updates 24/7

A Swiss medical agency has approved the Pfizer vaccine for children over the age of five.

In a decision issued on Friday, the Swiss for Therapeutic , Swissmedic, the use of the Pfizer in children aged 5-11.

“Swissmedic has thoroughly reviewed all of the information submitted with the application for an extension of the indications for the COVID-19 from Pfizer/BioNTech (Comirnaty®) by Pfizer/BioNTech. It will be possible for children aged 5 and to be against the new coronavirus (SARS-CoV-2) in accordance with the federal ’s updated vaccination recommendations as a result of the clinical results showing that the is safe and effective in this group “Swissmedic stated this in a statement posted on its website:

According to the agency, a involving more than 1,500 participants revealed that the provides almost complete against COVID-19 in children aged 5-11. According to the FDA, side effects included pain or tiredness at the injection site, as well as headaches, aches in the limbs, and fever in some , among others.

A total of 66 percent of Swiss nationals have received a COVID-19 vaccine, according to the most recent data available.

Leave A Reply

Your email address will not be published.

Comment moderation is enabled. Your comment may take some time to appear.